Supreme Court To Hear Case That May Reshape Biopharma Research

Supreme Court To Hear Case That May Reshape Biopharma Research

After months of anticipation, the US Supreme Court today will hear arguments about a case that raises crucial questions about whether human genes can be patented. And the outcome may well reset the boundaries and direction of medical research in the US, which of course has tremendous implications for investments made by the biopharmaceutical industry and the battle against many diseases, notably cancer.

ADVERTISEMENT | Global Compliance Seminar

Best Practices for FDA 510(k) | LIVE | May 17, 2013 | 01:00 PM PST | 04:00 PM EST | Duration: 60 Min| Product Code: 510(k)-011413 | Register Now!

Implementing Medical Device Complaint Handling System | LIVE Choose from Various Dates | 8:00 AM PST| 11 AM EST | Duration: 60 Min Product Code: MDCHS-400 | Register Now!
Writing Adequate and Effective SOPs | LIVE Choose from Various Dates | 8:00 AM PST| 11 AM EST | Duration: 60 Min Product Code: SOP-500 | Register Now!
Implementing EN ISO 13485:2012 | LIVE Choose from Various Dates | 8:00 AM PST| 11 AM EST | Duration: 60 Min Product Code: ISO 13485 | Register Now!
Demystifying Design History File (DHF), Device History Record (DHR), Device Master Record (DMR), and Design Control | LIVE Choose from Various Dates | 8:00 AM PST| 11 AM EST | Duration: 60 Min Product Code: DC-100 | Register Now!
Developing and Implementing a Global Regulatory Plan and Strategy | LIVE Choose from Various Dates, 08 AM PST | 11 AM EST | Duration: 60 Min | Product Code: DIRG-200 | Register Now!

The court will review a lower ruling that upheld the right of Myriad Genetics to patent two human genes that form the basis of a widely used genetic test for breast and ovarian cancers. A decision last year by a federal appeals court gave Myriad the right to patent two so-called isolated human genes – BRCA1 and BRCA2 – that account for most inherited forms of the cancer (here is the appeals court decision and here is the petition to the Supreme Court).

via Supreme Court To Hear Case That May Reshape Biopharma Research | Pharmalive.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s